Aberrant methylation of RASGRF1 is associated with an epigenetic field defect and increased risk of gastric cancer.
about
Recent advances in the molecular diagnostics of gastric cancerAn updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versaMagnifying narrow-band imaging of gastric mucosal morphology predicts the H. pylori-related epigenetic field defect.Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk.Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort studyHOXA11 gene is hypermethylation and aberrant expression in gastric cancer.c-Jun N-terminal kinase activation has a prognostic implication and is negatively associated with FOXO1 activation in gastric cancerLoss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancerAberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.Molecular pathogenesis of gastric cancer.miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1.Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae.Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.Next generation sequencing-based emerging trends in molecular biology of gastric cancer.Association of peripheral blood leukocyte KIBRA methylation with gastric cancer risk: a case-control study.
P2860
Q26785548-FEF3C562-ECD1-4F4E-B7F9-3C4E7BD53DF9Q27027592-48ACF60D-7F24-42EE-9E6D-37B809009D1AQ30855215-0E48C51C-C20B-40AE-BDE6-B59C760AD1EEQ33850782-7069706B-A8C8-4256-A328-92AAB462C7ECQ34719794-47129289-7968-4FB1-91E6-00057C095471Q35135769-7F0DD140-BE5D-4204-90F9-6C67E711E408Q35189387-538357B1-E185-4667-A8D6-41BC0DB4B443Q36042653-A2541130-D951-4D39-B278-55686716E44DQ36287390-A63C6AFF-9F2F-4DAD-9A71-91DF5F09D5D0Q36730582-2CDC0524-8C02-4B98-9C80-5E359962B294Q37488688-569F43B6-1FB3-4CEA-8BF1-32C82E6B40C9Q37517411-AAE2A3AF-6E12-4979-98E0-2FEEA9FA84EFQ38134870-2CAA134E-A761-44E8-9A15-E359D2733C6DQ38830047-5C86085D-79EE-4A9B-B5DA-441A6CA289BEQ41420061-CF5B22B5-72C8-419F-9636-5414F5E50ED7Q41495056-9CBA85BF-CAC2-42DD-BFC0-D43451B70185Q47561735-5F721F16-AEE5-41AA-B9A9-438142FBB80DQ54261019-CD4DE174-F98F-44AA-B26E-A5F052FA4693Q55339998-182B3F79-C43E-41E1-BFAA-1553C206DDB2
P2860
Aberrant methylation of RASGRF1 is associated with an epigenetic field defect and increased risk of gastric cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Aberrant methylation of RASGRF ...... reased risk of gastric cancer.
@en
Aberrant methylation of RASGRF ...... reased risk of gastric cancer.
@nl
type
label
Aberrant methylation of RASGRF ...... reased risk of gastric cancer.
@en
Aberrant methylation of RASGRF ...... reased risk of gastric cancer.
@nl
prefLabel
Aberrant methylation of RASGRF ...... reased risk of gastric cancer.
@en
Aberrant methylation of RASGRF ...... reased risk of gastric cancer.
@nl
P2093
P1476
Aberrant methylation of RASGRF ...... reased risk of gastric cancer.
@en
P2093
Eiichiro Yamamoto
Hiro-O Yamano
Hiromu Suzuki
Hiroyuki Takamaru
Hiroyuki Yamamoto
Kenjiro Yoshikawa
Kohzoh Imai
Masahiro Kai
Masami Ashida
Minoru Toyota
P304
P356
10.1158/1940-6207.CAPR-12-0056
P577
2012-09-07T00:00:00Z